Currently Viewing Posts in ktznejhg

The Dark Age

first_imgUncategorizedThe Dark AgeHandicapping the Oscar race in a year that’s been filled with doom-and-gloom story linesBy Steve Erickson – February 1, 2012348ShareEmailFacebookTwitterPinterestReddItIllustration by Andre CarrilhoThe best last line of any movie this past year was spoken by Jessica Chastain in Take Shelter. The line is: “OK.” It’s not just as big as the word “OK” can be—it’s bigger than you thought “OK” could ever be; in Chastain’s “OK” lies the end of the world. For the duration of writer-director Jeff Nichols’s film, her husband—played by Michael Shannon in a performance at once ferocious and hushed—has been tormented by apocalyptic dreams that have led him and everyone around him to question his sanity, which is exactly what leads the audience to suspect he’s not mad at all. In another 2011 movie, Hugo, an orphan boy who winds the clocks of Paris and lives within their gears and watchworks meets the “inventor of dreams,” as the film calls him—Georges Méliès, cinema’s earliest maestro, before the nightmare of his century would seem to have rendered trivial his hand-tinted celluloid wonders. Over the course of whatever time has transpired between the dreams of Méliès and of Shannon’s crazy prophet, the innocence of the former has given way to the only revelation that can dazzle us anymore, which is one of cataclysm.You could draft a respectable best-of-2011 list composed entirely of movies about the End of the World or about The Movies themselves. If it would be glib to say they’re the same thing (though a film like Super 8 is explicitly about both), they feel born of a common impulse—to pursue a vision as far as it can go, either inward or outward—and occupy opposite ends of the same dream. Moreover, what binds Take Shelter, Melancholia, Another Earth, Contagion, Rise of the Planet of the Apes, and The Tree of Life with Hugo, My Week with Marilyn, Road to Nowhere, and The Artist is how many of the films feel so 21st century—like they couldn’t have been made at any other moment—and so outside of time. With the exception of Marilyn, they’re all chronologically free floating in spirit. Stepping into the production of a movie called Road to Nowhere, the production crew of Monte Hellman’s film of the same name slips its temporal moorings; and the appearance of the parallel world (which looks just like the oncoming rogue planet of Melancholia) hovering above ours in Another Earth scrambles time’s calibrations and landmarks altogether. If anything, this may be more pronounced in movies as ostensibly period as Hugo and The Artist, which each tick to a metaclock: Their forecasts of the last century are infused with the perspective of this one. In many of these pictures there’s a sense that the act of filming itself has set Armageddon in motion. The silent world of a silent-film star in The Artist is ruptured when a water glass that he sets down on a table makes a noise. In Melancholia, the snap of director Lars von Trier’s clipboard brings on a cosmic car wreck unleashing emotional truths that are overwhelming before they become meaningless. To Terrence Malick, a family’s struggle in The Tree of Life to decode the meaning of a son’s death is futile outside the context of eons, even as the eons are sound and fury that signify nothing when unredeemed by the humanity of love and grief, resilience and grace.////When a theme dominates movie-years so strikingly, it’s tempting to make something of it because that’s what people like me are paid to do. But leaving aside the highlights that don’t neatly fit grand pronouncements (Tomas Alfredson’s first-rate adaptation of Tinker, Tailor, Soldier, Spy, for instance), the reality is that movies take varying numbers of years to get finished, and whether the director catches something in today’s zeitgeist, or yesterday’s, or tomorrow’s, or has bent the zeitgeist to his or her will, is a crapshoot; when a bunch of movies tap into the same thing, it’s as much an alignment of the stars as any collective conclusion. The movies mentioned above are variable in style and quality, from Road to Nowhere, which veers as close to the avant-garde as anything vaguely earning the label “mainstream,” to the conventional My Week with Marilyn, distinguished wholly by Michelle Williams, who—ever since seeing her husband kiss another man in Brokeback Mountain and registering more complicated emotion in a single look than anyone since Garbo at the end of Queen Christina—appears destined for immortality with each passing performance. Hugo is the homage to cinematic delirium that you would expect of a Martin Scorsese movie that looks more like a Steven Spielberg movie than Spielberg’s War Horse, and then there’s The Artist, which manages to be radical and populist at the same time. Nothing captures the culture’s attention deficit disorder better than the backlash to The Artist already setting in, and you can only hope that as the movie increasingly is dismissed as a shameless crowd pleaser, someone remembers now and then that a year ago anybody making a black-and-white silent film would have been called insane or named Guy Maddin. French director Michel Hazanavicius not only got away with it but got the world to love it, and unless the counter assault gathers momentum, which is possible, it will win the Academy Award.The true picture of the year is a trilogy, seven hours long and made unwittingly by its three directors. The Tree of Life, Take Shelter, and Melancholia are a biographical triptych of not just the species or the planet but of existence, ending not in mere death, which is survived by memory, but the void, which is survived by nothing. The family of The Tree of Life is very much like the one in Take Shelter; they could be next- door neighbors a few decades removed. The dead birds that fall from the sky in Take Shelter fall in Melancholia as well, and Melancholia’s doomed sisters, Kirsten Dunst and Charlotte Gainsbourg, are long-lost cousins of Shelter’s Shannon. The crashing of planets in Melancholia is alluded to by the celestial combustion of The Tree of Life, in which a wife and mother chooses ascension over primitivism, just as a wife and mother a generation or two later in Take Shelter practically and heroically chooses to overcome despair, with Chastain playing both women. Malick doesn’t think The Tree of Life is about the End at all—he thinks it’s about the Continuum—while Von Trier’s instinctive no-exit sensibility, not to mention the cruelty of his early work, are transformed by Melancholia into the kind of earthbound pity and insight that the characters in The Tree of Life never grasp until they’ve transcended its highest branches. OK, says Chastain on her back porch in Take Shelter’s final scene, to both the End of the World and her husband’s second sight that she doubted. OK, say Dunst’s eyes in Melancholia to both the End of the World and her sister’s desolation over her young son’s deliverance not to death but oblivion. OK, says Sean Penn’s face in The Tree of Life to an afterworld where all premature separations are reconciled and all paradises, once lost, are regained.     TAGS2012February 2012L.A. CulturePrevious articleTake 3 With Kathy GriffinNext articleThe Wednesday Afternoon Cram, 2/1/12Steve Erickson RELATED ARTICLESMORE FROM AUTHORFollow in Pee-wee Herman’s Footsteps Across L.A.What Defines a Successful Immigrant?The Undocumented Immigrants Who Are Redefining ‘American’last_img read more

Pharmalittle: Most Americans think Trump drug plan will not matter; Ohio readies lawsuit against PBMs

first_img Pharmalot Columnist, Senior Writer Ed covers the pharmaceutical industry. Pharmalot By Ed Silverman July 24, 2018 Reprints What’s included? Hello, everyone, and how are you today? We are doing just fine, thank you, as a comfortable breeze and hazy skies make the Pharmalot campus a rather comfortable work space this morning. Moreover, we fired up the coffee kettle on our way to brewing a steady supply of cups of stimulation. Our initial flavor this morning is blueberry, a summer special. Please feel free to join us. Remember, no prescription is required. So no rebates factor in to your cost. What more could you ask? Meanwhile, here are some tidbits. Hope you have a wonderful day and, of course, do keep in touch …Just 27 percent of Americans have heard or read about the Trump administration blueprint for reducing drug costs, a Politico poll finds. And 57 percent believe the plan will not make a difference, while 13 percent believe they or their family will pay more. Meanwhile, 22 percent believe the plan will lower the price they or their family pay for prescription drugs. And many more Americans believe drug makers — not pharmacy benefit managers — are responsible for high prices. Republicans are more likely than Democrats to believe the Trump plan will lower drug prices. What is it? [email protected] GET STARTED @Pharmalot About the Author Reprintscenter_img Alex Hogan/STAT Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+. First 30 days free. GET STARTED Pharmalittle: Most Americans think Trump drug plan will not matter; Ohio readies lawsuit against PBMs Ed Silverman Log In | Learn More Daily reporting and analysis The most comprehensive industry coverage from a powerhouse team of reporters Subscriber-only newsletters Daily newsletters to brief you on the most important industry news of the day STAT+ Conversations Weekly opportunities to engage with our reporters and leading industry experts in live video conversations Exclusive industry events Premium access to subscriber-only networking events around the country The best reporters in the industry The most trusted and well-connected newsroom in the health care industry And much more Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr. Tags Donald Trumpdrug pricinglegalpharmaceuticalspharmalittleSTAT+ STAT+ is STAT’s premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.last_img read more

What’s scary, and appealing, about real-world evidence

By STAT staff March 6, 2019 Reprints NewslettersSign up for The Readout Your daily guide to what’s happening in biotech. Last week STAT senior writer Matthew Herper wrote a story about a collaboration between Flatiron Health and the Food and Drug Administration, and a vexing topic called real-world evidence, which basically means the integration of types of data beyond clinical trials into the drug approval process. (You can read that story here.)On Tuesday, Herper held a chat with STAT Plus subscribers. Here is an edited partial transcript (emphasis on partial — subscribers got to go much deeper) on the topic, particularly the area of “synthetic controls,” which Herper called “the biggest idea, the most appealing, and the scariest.” It’s the idea that computer-curated sets of health records could sometimes replace placebo groups. Read on. And if you want to participate in future chats, subscribe to STAT Plus.Lexi G: How can real world data advance personalized healthcare/precision medicine? Any concrete examples?advertisement STAT staff Privacy Policy Related: Jason C: How do companies like FlatIron obtain electronic medical records? And what ability to patients have to either consent or deny their records be used as part of this ‘real world evidence’? Is there a bias introduced in who may or may not consent?Flatiron owns an EHR company, which is widely used by community oncologists. Patients have the ability to opt-out of having their data or records used. It’s a very fair question to ask whether patients know this or what the right informed consent process would be.Most patients consent. Also, there may be biases that are lost by patients not enrolling in a study and getting placebo. Is there a benefit to being in a clinical trial? If so, will a control arm constructed from EHR data be worse than what happens in a placebo group?  We need answers to ALL these questions, and we need to make sure we’ve fully considered the privacy issues as this becomes a bigger deal.Thomas J: Is the FDA really going to use this to approve drugs? Front office all talking about it but when you ask any staffers they think it’s statistical bs.This is the big question, isn’t it? I certainly think we’re going to see real-world evidence used for new indications before it’s used for new drug applications, and as supporting evidence before it’s accepted as a pivotal trial.One really obvious place to use RWE in oncology is in approvals that use single-arm trials and response rates, where right now there is no comparator. Would knowing how survival, progression-free survival, overall response rate and complete response rate compared to a matched control from the same time period help? Maybe. Even there, there’s going to have to be a lot more validation, because reviewers and outside experts are going to wonder what the heck they’re looking at.And that’s going to be the big issue, especially in cases (like oncology) where there may only be one source of data (say, Flatiron). Really, the use of real-world data is going to depend on a whole ecosystem of technologies developing that complement and support each other. We’ve seen three cases where real-world evidence was used in a drug approval — once for a first-time drug approval, and twice for an additional indication, according to Nancy Dreyer, the chief scientific officer at IQVIA, the clinical research organization.The first-time approval is for Bavencio, the PD-L1 inhibitor developed by Pfizer and Merck KGaA to treat metastatic Merkel cell carcinoma. Data were compared to a historical control of matched patients. Blincyto, from Amgen, received an additional approval for Philadelphia chromosome-negative relapsed and refractory B-cell precursor acute lymphoblastic leukemia based on a single-intervention group trial. The results were compared with historical data from 694 comparable patients extracted from 2,000 patient records in the U.S. and E.U.advertisement About the Author Reprints Please enter a valid email address. [email protected] Adobe HealthWhat’s scary, and appealing, about real-world evidence Leave this field empty if you’re human: Perhaps the most interesting example is Invega Sustenna, the Johnson & Johnson long-acting antipsychotic. This was a pragmatic real-world trial, a randomized trial that used measures that are collected in clinical practice. It showed a six-month delay in relapse for those that got this long-acting injection compared to a basket of seven antipsychotic pills, and the FDA did approve adding to the product’s label.But we’re still very much in the stage of defining what these tools are and what they mean.Andrew L: One of the most-discussed use cases of real-world evidence (both in the Flatiron piece and elsewhere) is around use as a “synthetic” control arm to reduce or eliminate the need for placebo or comparator arms in clinical trials. What do you see as the biggest roadblocks to adoption of this use case?This is the most discussed use case because it’s the biggest idea, the most appealing, and the scariest. There’s a lot of loaded emotion here on both sides, from patient advocates who don’t think cancer patients should ever have to receive placebo to clinical trialists who know from hard experience that only the answers from randomized clinical trials can really be trusted.Right now we’re seeing synthetic control arms most in cases where there is no control available, and the treatment difference is large. I think we’re going to need a lot more validation before we start augmenting (what Flatiron calls a hybrid control) or replacing the control groups in randomized controlled clinical trials.One of the biggest questions I have is how, if we move to a “synthetic” control world, we’ll know if the system breaks.It’s also important to emphasize: Researchers and the FDA are making a distinction between purely synthetic controls and those constructed from contemporaneous data. This is confusing, because most critics of synthetic controls don’t make this distinction, and are usually referring to controls constructed from contemporaneous data. Can Roche’s little tech startup help the FDA change clinical trials? read more

Capital One settles SEC auto loan charges

Mouth mechanic turned market manipulator James Langton Capital One agreed to pay $3.5 million to settle the SEC’s charges. Former chief risk officer, Peter Schnall, and former divisional credit officer, David LaGassa, also agreed to settle the charges against them relating to oversight failures. Schnall agreed to pay an $85,000 penalty and LaGassa agreed to pay a $50,000 penalty to settle the charges. They neither admitted, nor denied, the findings in consenting to the SEC’s order, which also requires them to cease and desist from any violations of federal securities laws. “Accurate financial reporting is a fundamental obligation for any public company, particularly a bank’s accounting for its provision for loan losses during a time of severe financial distress,” said George Canellos, co-Director of the SEC’S division of enforcement. “Capital One failed in this responsibility by underreporting expenses relating to its loan losses even as its own internal forecasting tool had signaled an increase in incurred losses due to the impending financial crisis.” Related news Facebook LinkedIn Twitter BFI investors plead for firm’s sale Keywords EnforcementCompanies Securities and Exchange Commission PwC alleges deleted emails, unusual transactions in Bridging Finance case Share this article and your comments with peers on social media While much of the global financial crisis was driven by turmoil in the U.S. subprime housing market, today the U.S. Securities and Exchange Commission (SEC) settled charges with Capital One Financial Corp., and two former executives, over allegations that it understated millions of dollars in auto loan losses. The SEC said its investigation found that Capital One failed to properly account for losses in its auto finance business in the second and third quarters of 2007 when they became higher than originally forecasted. It says that as credit markets began to deteriorate, Capital One’s internal loss forecasting tool found that the declining credit environment had a significant impact on its loan loss expense. However, it says the firm failed to properly incorporate these internal assessments into its financial reporting, and understated its loan loss expense by approximately 18% in the second quarter and 9% in the third quarter. read more

Vancouver Lake swim beach remains closed

first_img Subscribe Connect with LoginI allow to create an accountWhen you login first time using a Social Login button, we collect your account public profile information shared by Social Login provider, based on your privacy settings. We also get your email address to automatically create an account for you in our website. Once your account is created, you’ll be logged-in to this account.DisagreeAgreeNotify of new follow-up comments new replies to my comments I allow to use my email address and send notification about new comments and replies (you can unsubscribe at any time). Name*Email*Website guestLabel 0 Comments Inline FeedbacksView all comments guestLabelcenter_img Name*Email*Website I allow to create an accountWhen you login first time using a Social Login button, we collect your account public profile information shared by Social Login provider, based on your privacy settings. We also get your email address to automatically create an account for you in our website. Once your account is created, you’ll be logged-in to this account.DisagreeAgree Vancouver Lake swim beach remains closedPosted by ClarkCountyToday.comDate: Wednesday, July 31, 2019in: Community Newsshare 0 Tests continue to reveal elevated levels of E. coli bacteria VANCOUVER — Routine water quality testing at Vancouver Lake this week revealed elevated levels of E. coli bacteria. The swim beach at the lake is currently closed due to elevated levels of cyanotoxins in the water.Vancouver Lake swim beach remains closedTests continue to reveal elevated levels of E. coli bacteria in Vancouver Lake. As a result, the swim beach remains closed. Photo by Mike SchultzThe Vancouver Lake swim beach will remain closed until tests show cyanotoxins and E. coli bacteria levels do not exceed thresholds. Closure signs are currently posted at the swim beach and other public access points to the lake.Clark County Public Health continues to advise against all recreating in the lake, including swimming, kayaking, paddle boarding, canoeing and water skiing.Public Health has been monitoring cyanobacteria blooms at Vancouver Lake since June 12 and closed the swim beach on Wednesday after results revealed cyanotoxins above recommended threshold levels.On Monday, Public Health staff collected two sets of water samples from Vancouver Lake to test for bacteria and cyanotoxins. Results from water samples testing for bacteria came back today and showed elevated levels of E. coli bacteria. Results are pending for water samples collected to test for cyanotoxins. Those results are expected later this week.Public Health will continue to monitor the water at Vancouver Lake and update advisories as conditions change. Current advisories are posted on the Public Health public beaches website.Potential health risksBlue-green algae can pose a significant health risk if the cyanobacteria or toxins are ingested, inhaled or come into contact with skin. Inhaled bacteria or toxins can cause wheezing, coughing, chest tightness and shortness of breath. Skin contact can lead to rash, itching, blisters and eye irritation.If water with cyanotoxins is accidentally swallowed, symptoms can include abdominal pain, diarrhea, vomiting, numbness of the lips, tingling in fingers and toes, and dizziness. The toxins can be fatal to pets that drink the water.The presence of E. coli in Vancouver Lake water indicates that the water may contain bacteria found in animal or human feces. Some of these bacteria are capable of causing severe gastrointestinal illness.Depending on the cause, people with gastrointestinal infections may experience fever, abdominal pain, nausea, vomiting and/or diarrhea beginning several hours to several days or longer after exposure. Some infections may cause bloody diarrhea.Information provided by Clark Co. WA Communications.AdvertisementThis is placeholder textTags:Clark CountyVancouvershare 0 Previous : Share House catches fire; no injuries reported Next : Annexation discussion continues for Battle Ground and Clark County Fire District 3AdvertisementThis is placeholder textlast_img read more

Clark County Sheriff’s Office asking public for help to ID robbery suspect

first_imgClark County Sheriff’s Office asking public for help to ID robbery suspectPosted by ClarkCountyToday.comDate: Thursday, January 30, 2020in: Newsshare 0 Suspect is said to have robbed USA Federal Credit Union branch in Salmon CreekVANCOUVER — On Wednesday afternoon (Jan. 29), an unidentified male robbed a USA Federal Credit Union branch in Salmon Creek. Clark County Sheriff’s Office deputies are asking the public for help identifying the suspect.This unidentified man is alleged to have robbed the USA Federal Credit Union branch in the Salmon Creek Albertsons Wednesday afternoon. Photo courtesy of Clark County Sheriff’s OfficeThis unidentified man is alleged to have robbed the USA Federal Credit Union branch in the Salmon Creek Albertsons Wednesday afternoon. Photo courtesy of Clark County Sheriff’s Office At about 4:40 p.m. Wednesday, the subject entered the Alaska USA Federal Credit Union branch located within the Salmon Creek Albertsons at 14300 NE 20th Avenue and presented a demand note to the teller.  The subject fled the location on foot after receiving an undisclosed amount of cash.Suspect descriptionThe depicted subject appears to be an adult, white male between 20 and 30 years old, average height and build, with a black goatee style beard.  He was wearing a green rain coat (with hood pulled over his head), dark colored pants, a dark colored baseball cap, and black and white shoes. Anyone with information is asked to contact Detective Rick Osborne via email ([email protected]) or by phone (564) 397-2211 ext. 3354.Information provided by Clark County Sheriff’s Office.AdvertisementThis is placeholder textTags:Clark CountyLatestVancouvershare 0 Previous : Clark County Medical Examiner’s Office seeking help to ID deceased man Next : VIDEO: Sheriff’s Office and Washougal Police implement blood draw program for DUI investigationsAdvertisementThis is placeholder textlast_img read more

How safe are we if our cars can’t be seen?

first_imgCreated with Raphaël 2.1.2Created with Raphaël 2.1.2 Cars and truck cross the Quesnell Bridge along Whitemud Drive in Edmonton, Alta. The Rolls-Royce Boat Tail may be the most expensive new car ever We encourage all readers to share their views on our articles using Facebook commenting Visit our FAQ page for more information. Trending Videos Rear fog lamps. These have been popular in Europe for years but have never caught on here. They’re not designed to blind following drivers, but simply put a bright light down on the road surface just behind the rear bumper. They mostly only appear as one single light but certain models have two. Aftermarket suppliers carry a wide variety of 12-volt lamps and trailer lamps can easily be modified to fit most vehicles.   advertisement If you don’t want to rush out and buy a new vehicle just to change colours, consider reflective striping or vinyl cladding panels. They don’t have to look garish and many auto enthusiasts have come up with great patterns that improve the look of a vehicle and inexpensively take it from ho-hum to stand-out. Many glass and trim shops offer this service. Google ‘reflective pin-striping for cars’ images to get some ideas on how this can look. See More Videos COMMENTSSHARE YOUR THOUGHTScenter_img RELATED TAGSSafety and MaintenanceMaintenanceNew Vehicles PlayThe Rolls-Royce Boat Tail may be the most expensive new car everPlay3 common new car problems (and how to prevent them) | Maintenance Advice | Driving.caPlayFinal 5 Minivan Contenders | Driving.caPlay2021 Volvo XC90 Recharge | Ministry of Interior Affairs | Driving.caPlayThe 2022 Ford F-150 Lightning is a new take on Canada’s fave truck | Driving.caPlayBuying a used Toyota Tundra? Check these 5 things first | Used Truck Advice | Driving.caPlayCanada’s most efficient trucks in 2021 | Driving.caPlay3 ways to make night driving safer and more comfortable | Advice | Driving.caPlayDriving into the Future: Sustainability and Innovation in tomorrow’s cars | virtual panelPlayThese spy shots get us an early glimpse of some future models | How to get the most out of your car’s headlightsFirst is colour choice. The three top colours for passenger vehicles around the globe haven’t changed much in years and while they sometimes trade positions on the hit parade they are white, silver/grey, and black. The first makes our vehicles invisible in winter, the latter at night, and silver/grey is great for camouflaging our rides in almost any urban environment. So if you want to stand out in the crowd, consider another colour when shopping for a new ride. Trending in Canada The recent news from Transport Canada regarding vehicle lighting standards has many in the industry and outside of it, once again focused on lighting. As a reminder, starting in September of 2021 all new passenger vehicles sold in this country will be subjected to new exterior lighting regulations. They will be required to have all exterior lights power up automatically with the ignition, or have them controlled by a light sensor to operate in dim light conditions, or to have instrument clusters with no back lighting until the headlamps are turned on. All this is to answer the problem of drivers running their vehicles at dusk or in the dark with only their daytime running lights on.There are many ways to improve our vehicle’s visibility to other drivers and of course the first and best way is to simply turn on all the exterior lights every time. In darkness or dim light situations this is a no brainer, but even in good daylight it can make our rides stand out in a sometimes very crowded field. But there are others.RELATED ‹ Previous Next › Buy It! Princess Diana’s humble little 1981 Ford Escort is up for auction An engagement gift from Prince Charles, the car is being sold by a Princess Di “superfan”last_img read more

Bellevue and Psychiatric Wards at Hospitals to be Transformed

first_imgRelatedBellevue and Psychiatric Wards at Hospitals to be Transformed RelatedBellevue and Psychiatric Wards at Hospitals to be Transformed Bellevue and Psychiatric Wards at Hospitals to be Transformed Health & WellnessOctober 11, 2012 RelatedBellevue and Psychiatric Wards at Hospitals to be Transformedcenter_img FacebookTwitterWhatsAppEmail The Government is seeking to equip and transform the Bellevue Hospital in Kingston and psychiatric wards of the country’s hospitals into centres that can best care for the mentally ill. This was noted by Minister of Health, Hon. Dr. Fenton Ferguson, at the World Mental Health Day conference on October 10, at the Jamaica Conference Centre, downtown Kingston. The conference was held under the theme: ‘Depression: A Global Crisis’. “Our goal is to maintain a comprehensive, multifaceted treatment programme that revolves around: continuity of care; group and family therapy; environmental and social support and intervention; and community participation, support and control,” the Minister explained. He reaffirmed the Government’s commitment to addressing the issue of the modernisation of the mental health services, to make them more relevant to the times. “It is clear that the new focus has to be geared towards a greater emphasis on care in the community as opposed to institutionalisation,” he said. Dr. Ferguson added however, that there will always be a need for institutionalisation of some patients. The Minister informed that several policies and protocols have recently been developed that are integral to improving the quality of mental health care. These include: a guideline for the management of psychiatric emergencies was developed and distributed earlier this year; standardised restraints were purchased for use in hospitals and for emergencies in communities; and four buses were purchased for the community service. Dr. Ferguson also noted that the National Mental Health Policy and the Mental Health Legislation are undergoing revision; and a mental health handbook will be launched soon. Some of the issues examined at the conference were: ‘Depression in children’; ‘The economic impact of depression’; ‘Depression in a recession’; ‘Depression in chronic diseases and the elderly’; ‘Depression in care givers of the mentally ill’; and ‘Counselling tips in depression’. Advertisementslast_img read more

AT&T wins court appeal against data throttling ruling

first_img AddThis Sharing ButtonsShare to LinkedInLinkedInLinkedInShare to TwitterTwitterTwitterShare to FacebookFacebookFacebookShare to MoreAddThisMore 30 AUG 2016 T-Mobile US chief predicts market rebound Verizon shuffles executives Richard Handford Author Related A US appeals court ruled against a Federal Trade Commission (FTC) lawsuit that alleged AT&T misled subscribers over restricting their data speeds.The Court of Appeals for the Ninth Circuit reversed a lower district court’s ruling that supported the FTC’s case that AT&T had unfairly throttled users’ internet access.The FTC, which brought the case in 2014, claimed the US operator restricted millions of customers on unlimited data plans, after they had used as little as 2GB of data in a billing period.The agency claimed AT&T had not sufficiently warned users they might throttle speeds, sometimes by as much as 90 per cent.But the appeals court ruled in favour of the operator. The FTC Act, on which the agency based its case, contained a common carrier exemption in section 5.The FTC argued AT&T was not exempt under section 5 because mobile data is not considered a common carrier service.While the motion to dismiss was pending, the Federal Communications Commission reclassified mobile data from a non-common carrier service to a common carrier service. This classification was recently upheld in the June 2016 appeal.AT&T argued to the lower court that the FCC’s reclassification order, although being forward-looking rather than retrospective, stripped the FTC of its authority.The argument before the appeal court was whether the section 5 exemption should be status-driven, or activity-driven. The operator argued the former, and the court agreed. The FTC has not decided whether to appeal.However, AT&T could still face a fine from the FCC, which in June 2015 charged the operator $100 million over data throttling. AT&T is contesting that fine. FCC mulls expanded Huawei, ZTE bans Tags Previous ArticleLetterOne revealed as $50M FreedomPop backerNext ArticleApple must pay up to €13B in unpaid tax, says EC Home AT&T wins court appeal against data throttling ruling Richard is the editor of Mobile World Live’s money channel and a contributor to the daily news service. He is an experienced technology and business journalist who previously worked as a freelancer for many publications over the last decade including… Read more AT&TFCCFTCSprintT-Mobile USVerizonlast_img read more

Internet giants back net neutrality in FCC showdown

first_img FCC approves $7 billion for emergency connectivity Major technology firms represented by the Internet Association (IA) expressed “vigorous support” for net neutrality, as the lobby group urged Federal Communictions Commission (FCC) chairman Ajit Pai to keep the country’s current laws intact.Pai and other FCC commissioners met with the IA, which represents the interests of Facebook, Google, Amazon and others, after the chairman told major telecoms trade groups he planned to reverse net neutrality rules last week.The FCC chairman is believed to be working on a plan to gut the country’s 2015 Open Internet Order, which ensures all online traffic is treated equally, and instead implement a system whereby internet service providers (ISPs) enter into voluntary agreements to uphold the principle.In a statement released after the meeting, IA indicated it would oppose any attempts to repeal net neutrality laws.“IA continues its vigorous support of the FCC’s Open Internet Order, which is a vital component of the free and open internet,” said Michael Beckerman, president and CEO of IA. “The internet industry is uniform in its belief that net neutrality preserves the consumer experience, competition and innovation online. In other words, existing net neutrality rules should be enforced and kept intact.”The association continued to state its support for “light-touch” rules to protect the open internet, and these rules should be enforced “by the expert agency, namely the FCC”.According to reports, Pai also wants the Federal Trade Commission (FTC) rather than the FCC, to police fair treatment of web traffic under his future vision.All indications point to a showdown between net neutrality advocates and the major ISPs, should Pai, as expected, push to overturn the landmark Open Internet Order.However, IA’s statement did also suggest it could be willing to compromise in the future.“While IA continues its work to protect consumers by maintaining existing FCC rules, its primary focus is the end result – meaningful net neutrality rules that withstand the test of time,” it added. Tags Home Internet giants back net neutrality in FCC showdown FCC mulls expanded Huawei, ZTE bans AddThis Sharing ButtonsShare to LinkedInLinkedInLinkedInShare to TwitterTwitterTwitterShare to FacebookFacebookFacebookShare to MoreAddThisMore 13 APR 2017 Previous ArticleFacebook Messenger focuses on ads as users hits 1.2BNext ArticleBlackBerry wins $814.9M in Qualcomm royalty dispute Author FCC commissioner eyes further Chinese vendor curbs Kavit Majithia Related Kavit joined Mobile World Live in May 2015 as Content Editor. He started his journalism career at the Press Association before joining Euromoney’s graduate scheme in April 2010. Read More >> Read more Ajit PaiFCCInternet Assocationlast_img read more

  • Recent Posts

  • Recent Comments

    • Archives

    • Categories

    • Meta

    • Tags